A Post-Market, Multicenter, Prospective, Randomized, Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10 Therapy) Combined with Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Ne

The purpose of this Nevro-sponsored, post-market study is to document comparative safety, clinical effectiveness, and cost-effectiveness of the addition of Nevro HF10 therapy to Conventional Medical Management (CMM) compared with CMM alone in subjects with chronic, intractable, neuropathic lower limb pain due to diabetic neuropathy (Painful Diabetic Neuropathy or PDN). This study is a multi-center, prospective, randomized comparison of the two treatments.